(NaturalNews) A woman is suing the Irish government to compel it to withdraw the license for Merck’s Gardasil brand HPV vaccine, alleging that her daughter suffered “horrendous adverse effects” after receiving the vaccine as recommended under the Irish school vaccination program.

HPV refers to a large family of viruses, some of which can lead to cervical cancer, others of which can lead to warts, and many of which are harmless. Most HPV infections clear up on their own. Gardasil is a vaccine designed to prevent infection with two strains of HPV believed to be responsible for 70 percent of cervical cancer cases. Another HPV vaccine, GlaxoSmithKline’s Cervarix, protects against those two strains as well as against two strains that cause 90 percent of genital warts.

Court to hear evidence of severe side effects

The lawsuit was brought by Irish nurse Fiona Kirby, a member of the parental support group, Reaction and Effects of Gardasil Resulting in Extreme Trauma (REGRET). She is asking for the court to rescind Gardasil’s license for use in Ireland. She is also asking the court to issue an order preventing the Health Products Regulatory Agency (HPRA) from including Gardasil in any Irish vaccination programs.

Gardasil was added to Ireland’s school vaccination program in 2010, recommended for girls aged 11 to 16.

According to REGRET, approximately 100 Irish girls have reported illness following Gardasil vaccination since that time. Kirby’s lawsuit claims that her daughter developed severe flu-like symptoms within 24 hours of her first Gardasil shot in October 2011. The symptoms cleared up, but then returned after her daughter received the second dose. For this reason, Kirby did not give her daughter the third dose.

But following the second dose, Kirby says, her daughter suffered from severe nausea and fatigue leading to weight loss, muscle wasting and missed school. Kirby’s daughter was also hospitalized for bilateral pneumonia in March 2012. She is now disabled and needs permanent care.

The lawsuit claims that other girls have also experienced “similar continuous life changing health problems” following vaccination with Gardasil.

The case is on hold pending a reply from the HPRA.

Vaccine may not even work!

There are many doubts about the effectiveness of HPV vaccination, and at least one expert has warned that vaccination campaigns may actually lead to an increase in cervical cancer deaths.

Although many governments recommend that girls as young as 9 receive the Gardasil vaccine, there are in fact no tests of the drug’s effectiveness on girls under age 15. And according to a 2009 article in the New England Journal of Medicine, the vaccines have not yet been proved effective against HPV in the long-term, and have never been shown to actually reduce cancer rates. It is also unknown if they might produce cancer-related changes in immune function.

Another article in the same issue noted that because cervical cancer is very treatable if caught early, current Pap smear screening programs have already been highly effective at reducing cervical cancer death rates to nearly zero. Therefore, widespread vaccination is not actually a cost-effective way to protect against cervical cancer. Additionally, because vaccines are not 100 percent effective, because HPV vaccines do not protect against all cancer-causing strains, and because women already exposed to a cancer-related HPV stain cannot gain vaccine protection against that strain, vaccinated women still need to undergo yearly Pap tests.

Diane M. Harper, who has spent 20 years studying HPV and who did much of the work to develop the Gardasil vaccine, has widely criticized the way the vaccine is being promoted. She has expressed concerns that due to drug marketing, women may believe that HPV vaccination means they can stop getting yearly Pap smears. This would actually lead to an increase in cervical cancer deaths over time.

She has also expressed concern that vaccinating children may be pointless if the vaccine protection wears off before they are even sexually active.

Sources for this article include: